(Q36090658)

12 August 2017

1 reference

title

Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance (English)

1 reference

Jennifer McKimm-Breschkin

12 August 2017

author

series ordinal

1

0 references

publication date

1 January 2005

1 reference

Treatments in Respiratory Medicine

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

107-116

1 reference

https://scigraph.springernature.com/pub.10.2165/00151829-200504020-00004

12 August 2017

exact match

0 references

cites work

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

12 December 2020

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

1 reference

12 December 2020

The effect of zanamivir treatment on the early immune response to influenza vaccination

1 reference

12 December 2020

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

12 December 2020

Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir

1 reference

12 December 2020

Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.

1 reference

12 December 2020

Position statement: global neuraminidase inhibitor susceptibility network

1 reference

12 December 2020

Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors

1 reference

12 December 2020

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

1 reference

12 December 2020

Oseltamivir: a review of its use in influenza

1 reference

12 December 2020

Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series

1 reference

12 December 2020

Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice

1 reference

12 December 2020

Structure and diversity of influenza virus neuraminidase

1 reference

12 December 2020

Cost-effectiveness of newer treatment strategies for influenza

1 reference

12 December 2020

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

12 December 2020

Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

1 reference

12 December 2020

Oral oseltamivir treatment of influenza in children.

1 reference

12 December 2020

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

1 reference

12 December 2020

Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient

1 reference

12 December 2020

Oseltamivir: a clinical and pharmacological perspective

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives

1 reference

12 December 2020

Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine

1 reference

12 December 2020

Re-emergence of fatal human influenza A subtype H5N1 disease

1 reference

12 December 2020

Oral oseltamivir in human experimental influenza B infection.

1 reference

12 December 2020

Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial

1 reference

12 December 2020

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households

1 reference

12 December 2020

Influenza-A infection in children

1 reference

12 December 2020

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

1 reference

12 December 2020

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Neuraminidase inhibitors: zanamivir and oseltamivir

1 reference

12 December 2020

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

1 reference

12 December 2020

Neuraminidase inhibitors for the treatment and prevention of influenza

1 reference

12 December 2020

The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter

1 reference

12 December 2020

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

1 reference

12 December 2020

Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care.

1 reference

12 December 2020

Zanamivir: an update of its use in influenza

1 reference

12 December 2020

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

1 reference

12 December 2020

Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen

1 reference

12 December 2020

Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.

1 reference

12 December 2020

Experience with oseltamivir in the control of a nursing home influenza B outbreak

1 reference

12 December 2020

Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses

1 reference

12 December 2020

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

12 December 2020

Low incidence of rimantadine resistance in field isolates of influenza A viruses

1 reference

12 December 2020

Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis)

1 reference

12 December 2020

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

1 reference

12 December 2020

Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene

1 reference

12 December 2020

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

1 reference

12 December 2020

In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.

1 reference

12 December 2020

Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza

1 reference

12 December 2020

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

1 reference

12 December 2020

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

1 reference

12 December 2020

Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

1 reference

12 December 2020

Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.

1 reference

12 December 2020

Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial

1 reference

12 December 2020

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors

1 reference

12 December 2020

Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection.

1 reference

12 December 2020

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

1 reference

12 December 2020

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

12 December 2020

Oseltamivir (Tamiflu) unsafe in infants under 1 year old.

1 reference

12 December 2020

In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication

1 reference

12 December 2020

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

12 December 2020

1 reference

12 December 2020

Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers

1 reference

12 December 2020

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

1 reference

12 December 2020

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

1 reference

12 December 2020

Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

1 reference

12 December 2020

Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals

1 reference

12 December 2020

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

12 December 2020

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

1 reference

12 December 2020

10.2165/00151829-200504020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1008871983

0 references

PMC publication ID

7099216

0 references

1 reference